These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2632803)

  • 1. Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia.
    Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
    J Clin Lab Immunol; 1989 Jun; 29(2):65-9. PubMed ID: 2632803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preactivated T cells in cancer patients with poor prognosis.
    Fuchs DN; Fuith LC; Hausen A; Hetzel H; Reibnegger GJ; Werner ER; Wachter H
    Cancer Detect Prev; 1988; 12(1-6):97-103. PubMed ID: 3141055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
    Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The intraperitoneal installation of gamma interferon for the treatment of refractory ovarian carcinoma].
    Marth C; Mull R; Gastl G; Herold M; Steiner E; Daxenbichler G; Hetzel H; Flener R; Huber C; Dapunt O
    Geburtshilfe Frauenheilkd; 1989 Nov; 49(11):987-91. PubMed ID: 2511058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
    Freedman RS; Gutterman JU; Wharton JT; Rutledge FN
    J Biol Response Mod; 1983; 2(2):133-8. PubMed ID: 6644331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant leukocyte alpha interferon in advanced ovarian carcinoma.
    Niloff JM; Knapp RC; Jones G; Schaetzl EM; Bast RC
    Cancer Treat Rep; 1985; 69(7-8):895-6. PubMed ID: 4016797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of dysplasia of the cervical epithelium with an interferon gel.
    Møller BR; Johannesen P; Osther K; Ulmsteen U; Hastrup J; Berg K
    Obstet Gynecol; 1983 Nov; 62(5):625-9. PubMed ID: 6353302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.
    Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H
    Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer.
    Hetzel H; Bichler A; Fuchs D; Hausen A; Reibnegger G; Wachter H
    Cancer Detect Prev; 1983; 6(1-2):263-6. PubMed ID: 6883385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exfoliative cytology in the evaluation of interferon treatment of cervical intraepithelial neoplasia.
    Hsu C; Choo YC; Seto WH; Pang SW; Tan CY; Merigan TC; Ng MH
    Acta Cytol; 1984; 28(2):111-7. PubMed ID: 6583967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune activation in patients with ovarian cancers].
    Marth C; Moncayo R; Moncayo H; Fuith LC; Daxenbichler G
    Gynakol Rundsch; 1990; 30 Suppl 1():63-5. PubMed ID: 2127767
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients.
    Lissoni P; Barni S; Ardizzoia A; Scardino E; Tancini G; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(1):21-3. PubMed ID: 8553904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
    Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
    J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
    Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
    Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.